文献速递肾小球疾病

足细胞特异性诱导KLF15恢复分化标志物并减轻蛋白尿性肾损伤

Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2018-08-24

本研究在HIV-1转基因(Tg26)和阿霉素(ADR)诱导的蛋白尿小鼠模型中诱导足细胞特异性KLF15表达,发现可减轻足细胞损伤、肾小球硬化、肾小管间质纤维化及炎症,改善肾功能和生存;RNA测序提示KLF15激活肌动蛋白骨架稳定等通路,部分由WT1介导。

要点

  • 足细胞特异性诱导KLF15可减轻两种蛋白尿小鼠模型的肾损伤。
  • KLF15激活肌动蛋白骨架稳定、黏着斑和足细胞分化相关通路。
  • KLF15活性部分由WT1介导,提示其治疗蛋白尿性肾病的潜力。

核心结论

  • 足细胞特异性诱导KLF15通过直接和间接上调足细胞分化关键基因减轻肾损伤,可能成为治疗蛋白尿性肾病的策略。

研究设计与样本

  • 在HIV-1转基因(Tg26)小鼠和阿霉素(ADR)诱导肾病两种蛋白尿小鼠模型中诱导足细胞特异性KLF15。
  • 对Tg26小鼠分离的肾小球进行RNA测序及富集分析,并在培养的人足细胞中探索WT1的介导作用。

主要发现

  • 在Tg26小鼠中,诱导足细胞特异性KLF15减轻足细胞损伤、肾小球硬化、肾小管间质纤维化和炎症,改善肾功能和总体生存。
  • 在ADR处理小鼠中,诱导足细胞特异性KLF15也减轻足细胞损伤。
  • Tg26小鼠肾小球RNA测序富集分析显示,KLF15诱导激活肌动蛋白骨架稳定、黏着斑和足细胞分化相关通路。
  • 转录因子富集分析及实验验证提示KLF15活性部分由WT1介导。

临床怎么用

  • KLF15诱导可能作为蛋白尿性肾病(如FSGS和微小病变)的潜在治疗策略。
  • 其作用机制涉及稳定足细胞肌动蛋白骨架和促进分化,部分通过WT1实现。

局限性

  • 研究仅基于小鼠模型和体外培养足细胞,尚未在人体中验证。
  • KLF15诱导的具体治疗窗口和长期安全性未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Podocyte injury is the hallmark of proteinuric kidney diseases, such as FSGS and minimal change disease, and destabilization of the podocyte's actin cytoskeleton contributes to podocyte dysfunction in many of these conditions. Although agents, such as glucocorticoids and cyclosporin, stabilize the actin cytoskeleton, systemic toxicity hinders chronic use. We previously showed that loss of the kidney-enriched zinc finger transcription factor Krüppel-like factor 15 (KLF15) increases susceptibility to proteinuric kidney disease and attenuates the salutary effects of retinoic acid and glucocorticoids in the podocyte. METHODS: We induced podocyte-specific KLF15 in two proteinuric murine models, HIV-1 transgenic (Tg26) mice and adriamycin (ADR)-induced nephropathy, and used RNA sequencing of isolated glomeruli and subsequent enrichment analysis to investigate pathways mediated by podocyte-specific KLF15 in Tg26 mice. We also explored in cultured human podocytes the potential mediating role of Wilms Tumor 1 (WT1), a transcription factor critical for podocyte differentiation. RESULTS: In Tg26 mice, inducing podocyte-specific KLF15 attenuated podocyte injury, glomerulosclerosis, tubulointerstitial fibrosis, and inflammation, while improving renal function and overall survival; it also attenuated podocyte injury in ADR-treated mice. Enrichment analysis of RNA sequencing from the Tg26 mouse model shows that KLF15 induction activates pathways involved in stabilization of actin cytoskeleton, focal adhesion, and podocyte differentiation. Transcription factor enrichment analysis, with further experimental validation, suggests that KLF15 activity is in part mediated by WT1. CONCLUSIONS: Inducing podocyte-specific KLF15 attenuates kidney injury by directly and indirectly upregulating genes critical for podocyte differentiation, suggesting that KLF15 induction might be a potential strategy for treating proteinuric kidney disease.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Guo Y, Pace J, Li Z, et al. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease. J Am Soc Nephrol. 2018. PMID: 30143559. doi:10.1681/ASN.2018030324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。